Abstract:Efficient therapies for breast cancer remain elusive because of the lack of strategies for targeted transport and receptor-mediated uptake of synthetic drug molecules by cancer cells. Conjugation of nanoparticles (NPs) with active targeting ligands enabling selective molecular recognition of antigens expressed on the surface of cancer cells is promising for localization and treatment of malignant cells. In this study, covalent attachment of synthetic estrogen 17α-ethynylestradiol on the silica (SiO2) shell of silica-gold NPs (SiO2@Au) was undertaken to improve the cancer-targeting ability of the nano-biotags. Chemical and structural analysis of the bioconjugates examined in solution (UV–vis and ξ-potential) and solid state (Fourier transform infrared spectroscopy, X-ray diffractometry, and transmission electron microscopy) confirmed the identity of the carrier particles and surface-bound ligands. The mesoporous silica shell served as a reservoir for anticancer drugs (doxorubicin and quercetin) and to facilitate covalent attachment of receptor molecules by click chemistry protocols. The chemoselective recognition between the nanoconjugates and cell membranes was successfully demonstrated by the accumulation of nanoprobes in the tumor tissue of mice with subcutaneous breast cancer, whereas healthy cells were unaffected. The drug release studies showed sustained release kinetics over several weeks. These findings elaborate the exceptional selectivity and potential of estrogen-coated nano-biolabels in efficient diagnosis and detection of breast cancer cells.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.langmuir.0c02820?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.langmuir.0c02820</a>.TG–DSC of chloroauric acid tetrahydrate; size distribution of the as-prepared Au nanorods and of the shell thickness of mSiO2@Au NPs; UV–vis spectra of quercetin, quercetin-loaded mSiO2@Au NPs and released oxidized quercetin derivate 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxybenzofuran-3(2H)-one; calibration curve of quercetin and doxorubicin determined via UV–vis; autofluorescence of MCF-7 breast cancer cells; flow cytometry measurements of E0771 cells, incubated with AF647/Diol-mSiO2@Au NPs; and flow cytometry measurements of control mice treated with PBS (<a class="ext-link" href="/doi/suppl/10.1021/acs.langmuir.0c02820/suppl_file/la0c02820_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Porous Silica-Based Platform Bearing Au/Ag Nanosheets for Targeted Combination Therapy and Fluorescence Imaging

Multifunctional Fe3o4@C@Ag Hybrid Nanoparticles As Dual Modal Imaging Probes and Near-Infrared Light-Responsive Drug Delivery Platform

Fabrication of a smart drug delivery system based on hollow Ag2S@mSiO2 nanoparticles for fluorescence-guided synergistic photothermal chemotherapy

Tlyp-1-conjugated Au-nanorod@SiO(2) Core-Shell Nanoparticles for Tumor-Targeted Drug Delivery and Photothermal Therapy.

Mesoporous Silica-Encapsulated Gold Nanorods for Drug Delivery/Release and Two-Photon Excitation Fluorescence Imaging to Guide Synergistic Phototherapy and Chemotherapy.

Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform.

Characterization of Tumor-Targeting Ag2S Quantum Dots for Cancer Imaging and Therapy in Vivo.

One-Pot Synthesis Of Sustained-Released Doxorubicin Silica Nanoparticles For Aptamer Targeted Delivery To Tumor Cells

Construction of Double-Shelled Hollow Ag2S@Polydopamine Nanocomposites for Fluorescence-Guided, Dual Stimuli-Responsive Drug Delivery and Photothermal Therapy

Gold Nanoparticle-Gated Mesoporous Silica As Redox-Triggered Drug Delivery for Chemo-Photothermal Synergistic Therapy.

Gold Nanorods with Silica Shell and PAMAM Dendrimers for Efficient Photothermal Therapy and Low Toxic Codelivery of Anticancer Drug and Sirna

Biocompatible Au@Ag Nanorod@zif-8 Core-Shell Nanoparticles for Surface-Enhanced Raman Scattering Imaging and Drug Delivery

Lipid Bilayer Modified Gold Nanorod@mesoporous Silica Nanoparticles for Controlled Drug Delivery Triggered by Near-Infrared Light

Mesoporous silica-coated gold nanostars with drug payload for combined chemo-photothermal cancer therapy.

Mesoporous Silica Nanoparticles Combining Au Particles As Glutathione and Ph Dual-Sensitive Nanocarriers for Doxorubicin.

Near‐Infrared‐Light‐Induced Fast Drug Release Platform: Mesoporous Silica‐Coated Gold Nanoframes for Thermochemotherapy

Gold Nanoparticles Covered Hollow SiO2 Nanocapsules for DOX Delivery and Multiple Antitumor

Biodegradable Multifunctional Nanotheranostic Based on Ag<sub>2</sub>S-Doped Hollow BSA-SiO<sub>2</sub> for Enhancing ROS-Feedback Synergistic Antitumor Therapy

Fluorescent Carbon Dot-Gated Multifunctional Mesoporous Silica Nanocarriers for Redox/enzyme Dual-Responsive Targeted and Controlled Drug Delivery and Real-Time Bioimaging.

Aptamer-functionalized Molybdenum Disulfide Nanosheets for Tumor Cell Targeting and Lysosomal Acidic Environment/nir Laser Responsive Drug Delivery to Realize Synergetic Chemo-Photothermal Therapeutic Effects.

Receptor-Mediated In Vivo Targeting of Breast Cancer Cells with 17α-Ethynylestradiol-Conjugated Silica-Coated Gold Nanoparticles